Results 181 to 190 of about 24,071 (243)

Neovascular age-related macular degeneration: 18-month outcomes of aflibercept treatment in patients resistant to ranibizumab

, 2018
Elif Ertan, Mustafa Doğan
openalex   +2 more sources

Switching From Aflibercept 2 mg to 8 mg in Vitrectomized Eyes With Neovascular Age-Related Macular Degeneration. [PDF]

Cureus
Tamai R, Nizawa T, Kawamata Y, Iwase T, Baba T.   +4 more
europepmc   +1 more source

Choroidal Vascular Remodeling and Retinal Response After Aflibercept Loading in Diabetic Macular Edema. [PDF]

Ophthalmol Sci
Han YE, Choi L, Jung D, Kim Y, Kim SJ, Kim YJ, Yoon YH, Lee J.   +7 more
europepmc   +1 more source

Combined Pharmacological and Pneumatic Displacement Therapy for Sub-Macular Haemorrhage Secondary to Age-Related Macular Degeneration: A Case Series and Review of the Literature. [PDF]

Life (Basel)
Kudasiewicz-Kardaszewska A, Ozimek MA, Urbański T, Jamontt K, Tkaczenko A, Bonińska K, Cisiecki S.   +6 more
europepmc   +1 more source

Analysis of correlations between biomarkers assessed with swept-source OCT and OCT angiography in naïve patients with diabetic macular edema treated with aflibercept: a prospective study. [PDF]

Int J Retina Vitreous
Rezende MP, Faria FA, Beraldo DP, Polido J, Belfort R, Cabral T.   +5 more
europepmc   +1 more source

Reply to comment on: Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience

, 2018
Muna Bhende, Aditya Bansal, Tarun Sharma, Pramod Bhende, Suchetana Mukherjee   +4 more
openalex   +1 more source

Intravitreal Aflibercept for the Treatment of Diabetic Retinopathy Among Patients Who Completed PANORAMA: 1-Year Outcomes from the VOYAGE Extension Study. [PDF]

J Pers Med
Zhou AW, Teagle GM, Baumann LM, Cao JA, Emanuelli A, Hu AY, Berger AS, Major JC, Lee SY, Huddleston SM, Gonzalez VH, Clark WL, Liao DS, Kingsley RM, Lazarus HS, Payne JF, Feinstein EG, Meleth AD, Patel SB, Fan KC, Berliner AJ, Moini H, Niu X, Ip MS, Sadda SR, Al-Khersan H, Wykoff CC.   +26 more
europepmc   +1 more source

Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept

, 2012
Michael W. Stewart
openalex   +2 more sources

Aflibercept for Wet Age-Related Macular Degeneration: A Prospective, Randomized Trial Comparing Treat-And-Extend and Fixed Bimonthly Dosing. [PDF]

J Clin Med
Wu KY, Qian SY, Camiré A, Kim DT, Giunta M.   +4 more
europepmc   +1 more source

A comparison of the therapeutic response between brolucizumab and aflibercept in the HAWK & HARRIER trials using deep learning-based OCT analysis

, 2020
Ursula Schmidt‐Erfurth, Zufar Mulyukov, Bianca S. Gerendas, Philippe Margaron, Daniel Lorand, Hrvoje Bogunović, Georges Weissgerber   +6 more
openalex   +1 more source